At Sotheby's Auction, Space Sells, Einstein Doesn't

March 16 was not the best of days for Sotheby's, the venerable New York auction house. Albert Einstein failed to sell, and Ross Perot failed to buy. HIGH-FLYING FIDO: This 1959 prototype canine high-altitude, partial-pressure suit for use in Soviet suborbital biological research flights sold for $25,300. A 72-page Einstein manuscript on special relativity, which first sold for $1.2 million in 1987, did not attract any bidders above the confidential minimum price. Earlier the same day, Sotheb

Written byBilly Goodman
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

March 16 was not the best of days for Sotheby's, the venerable New York auction house. Albert Einstein failed to sell, and Ross Perot failed to buy.

HIGH-FLYING FIDO: This 1959 prototype canine high-altitude, partial-pressure suit for use in Soviet suborbital biological research flights sold for $25,300.
A 72-page Einstein manuscript on special relativity, which first sold for $1.2 million in 1987, did not attract any bidders above the confidential minimum price. Earlier the same day, Sotheby's held its second auction of Russian space artifacts. The first, in December 1993, had been wildly successful, with bidders buying 95 percent of all lots offered, often at prices well over pre-sale estimates.

The big buyer at the 1993 auction-not widely known-was Ross Perot, Texas billionaire and 1992 presidential candidate. He bought eight of the 10 highest-priced lots, including a Soyuz space capsule for $1,652,500; three space suits for a total of $600,000; ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies